Current Report Filing (8-k)
January 12 2022 - 6:02AM
Edgar (US Regulatory)
0000727346
false
0000727346
2022-01-06
2022-01-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 6, 2022
SELECTIS
HEALTH, INC.
(Exact
Name of Registrant as Specified in its Charter)
Utah
|
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of
incorporation)
|
|
Commission
File
Number
|
|
(I.R.S.
Employer
Identification
number)
|
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐
|
Written
communications pursuant to Rule 425 under the Securities Act
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM 3.02
|
UNREGISTERED SALE OF EQUITY SECURITIES
|
The
following sets forth the information required by Item 701 of Regulation S-B with respect to the unregistered sales of equity securities
by Selectis Health, Inc., a Utah corporation (the “Company”):
|
a.
|
Effective
January 6, 2022, in connection with the execution of Financial Public Investor Relations
Agreement described in Item 8.01 below, the Company granted to Gateway Group, Inc., a California
corporation an option to purchase 30,000 shares of common stock of the Company at an exercise
price of $6.00 per share (the “Option”). The Option has a cashless exercise provision,
is fully vested as of January 6, 2022, and is exercisable for a period of three years.
|
|
b.
|
The
Company paid no fees or commissions in connection with the issuance of the Option.
|
|
c.
|
The
sale of the Option was undertaken without registration under the Securities Act in reliance upon an exemption from the registration
requirements of the Securities Act set forth in Sections 4(2) thereunder. We did not engage in any public advertising or general
solicitation in connection with this transaction, and we provided the investor with disclosure of all aspects of our business, including
providing the investor with our reports filed with the Securities and Exchange Commission and other financial, business and corporate
information.
|
On
January 6, 2022 the Company executed a Financial Public Investor Relations Agreement (the “Agreement”) with Gateway Group,
Inc., a California corporation (the “Consultant”) to provide non-exclusive consulting services to the Company. The initial
term of the Agreement is for twelve (12) months and shall automatically renew every month thereafter unless terminated by either party.
As compensation, the Company has agreed to pay to the Consultant a monthly fee of $6,000 and as an additional incentive has granted to
the Consultant the Option described above in Item 3.02. A copy of the Agreement is filed herewith as Exhibit 99.1.
ITEM 9.01:
|
FINANCIAL STATEMENTS AND EXHIBITS
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
Selectis
Health, Inc.
|
|
(Registrant)
|
|
|
Dated:
January 11, 2022
|
/s/
Lance Baller
|
|
Lance
Baller, CEO
|
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Apr 2024 to May 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From May 2023 to May 2024